Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

VANTIVE US HEALTHCARE LLC

Filed by VANTIVE US HEALTHCARE LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
Not reported
Expenses
$390,000.00
Filing UUID
939b21d8-8850-44d3-9765-5ce2c46894d1
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Issues related to tariffs including issues related to Section 232 investigation of medical devices. Issues related to medical technology trade.

MMM · Medicare/Medicaid

Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring. H.R. 4441 - Patient Access to Innovative New Technologies Act, Issues related to sepsis device breakthrough designation.

Literal federal measure citations: H.R. 8319, H.R. 4441

HCR · Health Issues

Issues related to ESRD reimbursement H.R. 8319 - KIDNEY Remote Monitoring Act, Issues related to physician reimbursement for remote patient monitoring

Literal federal measure citations: H.R. 8319

FOR · Foreign Relations

Issues related to U.S. global health program priorities

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.